[1]
O. Ostrovskaya, M. Sips, P. Ulrichts, L. Trainor, P. Verheesen, and I. Stoykov, “Efgartigimod: Clinical Development of a Novel FcRn Antagonist in the Treatment of Autoimmune Diseases”, J of Skin, vol. 7, no. 2, p. s193, Mar. 2023.